x |
| BioScrip Diagnosed by StockDiagnostics.com with EPS Syndrome |
|
Stock Quote: (NGM:BIOS) |
| 11/09/2009 |
|
| 6.65 |
+0.03 |
+0.45% |
183,274 |
|
| BioScrip Diagnosed by StockDiagnostics.com with EPS Syndrome |
|
| Last |
Price Change |
% Chg |
Volume |
|
|
Sarasota, FL, November 9, 2009-StockDiagnostics.com has suspended its OPS ranking for BioScrip, Inc. (NASDAQ:BIOS) in its quarter ended September 30, 2009 because of its diagnosis of The EPS Syndrome. ... read full story |
|
|
|